NewEdge Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $695K | Buy |
|
|||||
|
2025
Q2 | $229K | Buy |
|
|||||
|
2025
Q1 | $270 | Sell |
|
|||||
|
2024
Q4 | $229K | Buy |
|
|||||
|
2024
Q3 | $275 | Sell |
|
|||||
|
2024
Q2 | $242K | Buy |
|
|||||
|
2024
Q1 | $2.69K | Buy |
|
|||||
|
2023
Q4 | $765 | Hold |
|
|||||
|
2023
Q3 | $708 | Hold |
|
|||||
|
2023
Q2 | $760 | Hold |
|
|||||
|
2023
Q1 | $801 | Sell |
|
|||||
|
2022
Q4 | $13.8K | Buy |
|